Original Literature | Model OverView |
---|---|
Publication
Title
The interrelated role of fibronectin and interleukin-1 in biomaterial-modulatedmacrophage function.
Affiliation
School of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave., Madison,WI 53705, USA.
Abstract
Macrophages play a critical role in mediating the host response to biomaterials,perhaps most notably by guiding the host inflammatory response through therelease of inflammatory molecules such as the cytokine interleukin-1 (IL-1). Theextent of the macrophage response following interaction with the biomaterialsurface contributes greatly to device efficacy, yet the molecular mechanisms ofthis interaction are still unclear. The extracellular matrix (ECM) proteinfibronectin (FN) is recognized by macrophages and frequently used in biomaterialmodification to elicit greater cellular adhesion and tissue integration.Macrophage interaction with FN and other ECM molecules on the biomaterialsurface has been shown to induce a variety of inflammatory responses, thus bothFN and IL-1 can be utilized as model molecules to better understand themechanisms of material-mediated macrophage responses. This literature reviewpresents a comprehensive survey of past and current research on the interrelatedrole of IL-1, FN, and FN-derivatives in determining biomaterial-modulatedmacrophage function.
PMID
16978691
|
Entity
IL-1beta
--
G010389
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93364
10
infinite
0
TRANSFAC | G010389 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IL-1beta
--
MO000016597
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1591
10
infinite
0
TRANSPATH | MO000016597 |
--
IL-1RA
--
MO000016598
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1592
10
infinite
0
InterPro | IPR003297 |
TRANSPATH | MO000016598 |
--
fibronectin
--
MO000017549
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2341
10
infinite
0
InterPro | IPR006209 |
TRANSPATH | MO000017549 |
--
proIL-1beta
--
MO000019449
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4012
10
infinite
0
InterPro | IPR003297 |
TRANSPATH | MO000019449 |
--
IL-1RI:IL-1RA
--
MO000039107
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m17283
10
infinite
0
TRANSPATH | MO000039107 |
--
collagen
--
MO000083632
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m57739
10
infinite
0
TRANSPATH | MO000083632 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
Beta1-integrin:Beta1-integrin antibody
--
e10
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m10
0
infinite
0
--
IL-1beta:IL-1RII
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
pro IL-1beta:IL-1RII
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
Fibronectin:Heparin
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
Fibronectin:collagen
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
Fibronectin:Fibrinogen
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
Cellular surface integrin receptors
--
e17
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
Fibronectin:cellular surface integrin receptors
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
GM-CSF:GM-CSFR
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
IL-1ra
--
e20
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m20
0
infinite
0
--
TNF-alpha receptor
--
e21
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
TNF-alpha:receptor
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
Bacteria
--
e23
cso30:c:Cell
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
surface receptor
--
e24
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
Bacteria:surface receptor
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
Beta1-integrin antibody
--
e26
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
csml-variable:Double
m27
0
infinite
0
--
pp76{p}
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
pp76
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Anti Beta1-integrin
--
e30
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m30
0
infinite
0
--
antibet3-integrin antibody
--
e31
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m31
0
infinite
0
--
IL-1beta:IL-1RI
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
ICE
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Pro IL-1alpha
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c3 : 1
stoichiometry:c2 : 1
m4012*m5*0.1
nodelay
--
0
PMID: 16978691, The two agonists, IL-1greek alpha and IL-1beta, both initially are synthesized as 31 kDa precursors, pro-IL-1greek small letter alpha and pro-IL-1¦Â, which are then cleaved into their mature 17 kDa forms PMID: 16978691 IL-18 is cleaved via the same enzyme, IL-1 converting enzyme (ICE), as IL-1¦Â, although the biological effects can differ.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m17*m2341*0.1
nodelay
--
0
PMID: 16978691,12244123,10077553 FN contains multiple binding sites which bind to other molecules such as heparin (heparin I and II), collagen (Type I module, domains 6?9 (I6¡Ý9) and Type II module, domains 1 and 2 (II1,2)), fibrin (Fibrin I and II), and cellular surface integrin receptors which bind via the cell-binding repeats (I1¡Ý9,II1,2, and III9¡Ý10)
p11
p11
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m57739*0.1
nodelay
--
0
PMID:16978691 Collagen was found to stimulate the greatest mRNA expression, followed by FN, while fibrin was found to induce little to no IL-1beta mRNA expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m18*0.1
nodelay
--
0
PMID:16978691 Collagen was found to stimulate the greatest mRNA expression, followed by FN, while fibrin was found to induce little to no IL-1beta mRNA expression.
p13
p13
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m88*m81*0.1
nodelay
--
0
PMID: 16978691,1386877 GM-CSF and TNF-alpha may also further induce the production of IL-1ra
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c38 : 1
stoichiometry:c37 : 1
m20*m19*0.1
nodelay
--
0
PMID: 16978691,1386877 GM-CSF and TNF-alpha may also further induce the production of IL-1ra
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m230*m21*0.1
nodelay
--
0
PMID: 16978691,1386877 GM-CSF and TNF-alpha may also further induce the production of IL-1ra
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m20*m22*0.1
nodelay
--
0
PMID: 16978691,1386877 GM-CSF and TNF-alpha may also further induce the production of IL-1ra
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m23*m24*0.1
nodelay
--
0
PMID: 16978691 Bacteria can bind to the surface receptors of host cells, including macrophages, through bacterial fimbriae.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c52 : 1
m27*m26*0.1
nodelay
--
0
PMID: 16978691 Beta1 integrin binding with anti-integrin ¦Â1 antibody resulted in an increase in phosphorylation of pp76 and an increase in IL-1beta mRNA expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c53 : 1
stoichiometry:c51 : 1
m29*m10*0.1
nodelay
--
0
PMID: 16978691 Beta1 integrin binding with anti-integrin ¦Â1 antibody resulted in an increase in phosphorylation of pp76 and an increase in IL-1beta mRNA expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m6*0.1
nodelay
--
0
PMID: 16978691, The two agonists, IL-1greek alpha and IL-1beta, both initially are synthesized as 31 kDa precursors, pro-IL-1greek small letter alpha and pro-IL-1¦Â, which are then cleaved into their mature 17 kDa forms
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m28*0.1
nodelay
--
0
PMID: 16978691 Beta1 integrin binding with anti-integrin ¦Â1 antibody resulted in an increase in phosphorylation of pp76 and an increase in IL-1beta mRNA expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m30*0.1
nodelay
--
0
PMID: 16978691 In parallel with the IL-1beta study, anti-beta1 integrin and anti-beta3 integrin antibody pre-treatment also resulted in a general decrease in matrix metalloprotease-2 (MMP-2) and matrix metalloprotease-9 (MMP-9) secretion and mRNA expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m31*0.1
nodelay
--
0
PMID: 16978691 In parallel with the IL-1beta study, anti-beta1 integrin and anti-beta3 integrin antibody pre-treatment also resulted in a general decrease in matrix metalloprotease-2 (MMP-2) and matrix metalloprotease-9 (MMP-9) secretion and mRNA expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m93364*0.1
nodelay
--
0
PMID: 16978691,1386877 GM-CSF and TNF-alpha may also further induce the production of IL-1ra
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c60 : 1
m1591*m1589*0.1
nodelay
--
0
PMID: 16978691 IL-1 alpha, IL-1beta, and IL-1ra all bind to the biologically active IL-1RI receptor, however IL-1¦Â binds somewhat less efficiently than the other cytokines.
p3
p4
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c10 : 1
m1592*m1589*0.1
nodelay
--
0
PMID: 16978691 IL-1 alpha, IL-1beta, and IL-1ra all bind to the biologically active IL-1RI receptor, however IL-1¦Â binds somewhat less efficiently than the other cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
stoichiometry:c13 : 1
m1591*m1590*0.1
nodelay
--
0
PMID: 16978691 IL-1RII binds 10?100 times more preferentially to IL-1¦Â than IL-1 alpha or IL-1ra and in soluble form can even bind pro-IL-1beta
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
stoichiometry:c16 : 1
m4012*m11*0.1
nodelay
--
0
PMID: 16978691 IL-1RII binds 10?100 times more preferentially to IL-1¦Â than IL-1 alpha or IL-1ra and in soluble form can even bind pro-IL-1beta
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m2341*m356124*0.1
nodelay
--
0
PMID: 16978691,12244123,10077553 FN contains multiple binding sites which bind to other molecules such as heparin (heparin I and II), collagen (Type I module, domains 6?9 (I6¡Ý9) and Type II module, domains 1 and 2 (II1,2)), fibrin (Fibrin I and II), and cellular surface integrin receptors which bind via the cell-binding repeats (I1¡Ý9,II1,2, and III9¡Ý10)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m2341*m57739*0.1
nodelay
--
0
PMID: 16978691,12244123,10077553 FN contains multiple binding sites which bind to other molecules such as heparin (heparin I and II), collagen (Type I module, domains 6?9 (I6¡Ý9) and Type II module, domains 1 and 2 (II1,2)), fibrin (Fibrin I and II), and cellular surface integrin receptors which bind via the cell-binding repeats (I1¡Ý9,II1,2, and III9¡Ý10)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m2341*m2254*0.1
nodelay
--
0
PMID: 16978691,12244123,10077553 FN contains multiple binding sites which bind to other molecules such as heparin (heparin I and II), collagen (Type I module, domains 6?9 (I6¡Ý9) and Type II module, domains 1 and 2 (II1,2)), fibrin (Fibrin I and II), and cellular surface integrin receptors which bind via the cell-binding repeats (I1¡Ý9,II1,2, and III9¡Ý10)
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--